respiratori
infect
import
caus
morbid
mortal
worldwid
diseas
burden
estim
almost
disabl
adjust
life
year
dali
death
per
year
sever
studi
show
respiratori
infect
promin
impact
pediatr
popul
assum
preschool
children
experi
viral
infect
per
year
older
children
adolesc
adult
experi
per
year
clinic
present
viral
respiratori
infect
depend
heavili
patient
statu
pathogen
involv
may
show
broad
varieti
symptom
includ
upper
eg
common
cold
rhiniti
sinus
otiti
media
lower
respiratori
symptom
eg
pneumonia
bronchopneumonia
bronchiti
bronchiol
tracheiti
croup
rapid
accur
detect
identif
virus
caus
respiratori
tract
infect
import
patient
care
diseas
control
significantli
decreas
length
hospit
reduc
manag
cost
furthermor
detect
identif
etiolog
agent
enabl
introduct
specif
antivir
treatment
appropri
isol
precaut
sever
case
despit
etiolog
agent
identifi
patient
suffer
respiratori
tract
diseas
previou
studi
hypothes
might
due
presenc
yet
unknown
virus
viru
detect
type
tediou
task
presenc
multipl
viral
speci
strain
blur
imag
infect
wide
rang
pathogen
may
result
similar
clinic
outcom
numer
clinic
virolog
laboratori
continu
employ
diagnost
algorithm
incorpor
antigen
culturebas
method
latter
sever
drawback
technic
demand
labori
furthermor
virus
replic
cell
cultur
eg
human
bocaviru
human
coronaviru
panel
suscept
cell
line
limit
undeni
advantag
approach
recov
viral
strain
valuabl
pathogen
character
antivir
suscept
test
antigenbas
method
use
detect
type
pathogen
clinic
sampl
cell
cultur
sever
assay
develop
although
high
variabl
virus
may
pose
problem
lead
falseneg
result
indisput
sensit
specif
method
detect
respiratori
virus
molecular
techniqu
molecular
method
may
roughli
divid
sensit
specif
assay
realtim
pcr
loopmedi
isotherm
amplif
lamp
method
techniqu
broad
specif
capabl
detect
wide
varieti
pathogen
latter
group
includ
sequenceindepend
method
eg
viru
discoveri
base
cdnaaflp
vidisca
sequenceindepend
singleprim
amplif
sispa
differenti
display
main
disadvantag
approach
sensit
assay
limit
method
rel
labori
highthroughput
analysi
unwork
previous
develop
method
eg
univers
primer
microarraybas
method
design
detect
broad
rang
target
combin
least
partial
advantag
two
approach
present
studi
human
ciliat
airway
epitheli
cell
cultur
use
combin
newli
develop
set
nest
pcr
assay
broad
specif
abl
detect
known
strain
respiratori
virus
disregard
coinfect
genet
variabl
materi
contain
clinic
sampl
assay
design
base
avail
sequenc
data
human
respiratori
virus
therefor
one
may
assum
may
enabl
detect
previous
uncharacter
viral
strain
combin
highli
sensit
cultur
system
set
optim
molecular
assay
allow
improv
detect
clinic
sampl
hypothesi
verifi
use
set
clinic
sampl
patient
suffer
respiratori
diseas
design
sensit
specif
assay
avail
sequenc
public
databas
analyz
primer
design
base
sequenc
analysi
facilit
identif
conserv
region
within
viral
genom
primer
blast
show
signific
similar
human
genom
sequenc
primer
pair
best
thermodynam
paramet
chosen
subsequ
studi
select
primer
pair
list
tabl
primer
use
detect
rhinovirus
previous
describ
found
superior
assay
primer
set
develop
silico
evalu
experiment
setup
briefli
primer
set
test
posit
control
materi
result
product
analyz
agaros
gel
sever
optim
step
allow
select
pcr
condit
common
reaction
includ
primer
concentr
amount
templat
pcr
profil
test
assay
perform
set
plasmid
contain
genet
element
recogn
certain
primer
prepar
plasmid
use
input
nest
pcr
result
product
analyz
agaros
gel
reaction
result
appear
specif
band
figur
show
whether
possibl
detect
viral
pathogen
clinic
materi
set
viru
cultur
supernat
clinic
isol
prepar
contain
rsv
influenza
b
virus
parainfluenza
virus
human
bocaviru
human
adenoviru
human
metapneumoviru
human
respiratori
enteroviru
viru
titer
determin
cultiv
pathogen
sampl
dilut
per
ml
pathogen
cultur
sampl
dilut
time
use
input
amplif
select
clinic
sampl
patient
present
obviou
clinic
symptom
respiratori
diseas
test
neg
respiratori
virus
use
dilut
media
result
pcr
product
visual
agaros
gel
shown
figur
clearli
posit
sampl
yield
band
correspond
size
predict
product
inhibit
pcr
reaction
observ
clinic
sampl
amplif
detect
neg
control
sequenc
confirm
ident
pcr
product
serial
dilut
control
plasmid
contain
genet
element
recogn
pcr
primer
use
determin
sensit
assay
briefli
assess
plasmid
concentr
use
two
independ
method
gel
electrophoresi
spectrophotometr
plasmid
copi
number
set
serial
dilut
one
microlit
templat
use
input
pcr
reaction
result
present
figur
show
assay
sensit
vari
copi
templat
nucleic
acid
per
reaction
care
optim
show
assay
sensit
could
increas
increas
primer
concentr
first
pcr
nm
detect
level
copi
per
reaction
reach
unfortun
sensit
imag
becom
blur
difficult
interpret
due
appear
nonspecif
product
distort
seen
clinic
sampl
like
presenc
nucleic
acid
origin
eukaryot
cell
nonspecif
bind
dome
primer
data
shown
determin
whether
newli
design
assay
specif
select
pathogen
primer
pair
test
crossreact
respiratori
pathogen
includ
studi
briefli
rna
dna
isol
concentr
cell
cultur
sampl
clinic
specimen
subject
revers
transcript
appropri
result
cdna
use
input
nest
pcr
use
primer
set
shown
tabl
crossreact
detect
assay
confirm
high
specif
pcr
reaction
figur
total
sampl
subject
analysi
briefli
rna
dna
isol
sampl
process
describ
materi
method
sampl
use
input
nest
pcr
develop
within
current
studi
result
present
tabl
show
etiolog
agent
identifi
case
frequenc
occurr
certain
speci
consist
avail
literatur
data
furthermor
two
pathogen
identifi
sampl
case
tabl
figur
mention
previous
etiolog
agent
found
clinic
specimen
patient
suffer
respiratori
tract
ill
similar
detect
rate
observ
current
studi
therefor
fullydifferenti
hae
cultur
figur
inocul
clinic
specimen
remain
undiagnos
standard
assay
total
sampl
test
apic
wash
collect
follow
incub
h
h
postinocul
rna
dna
sampl
isol
submit
nest
pcr
analysi
combin
sensit
develop
diagnost
set
potenc
hae
cultur
result
viral
pathogen
detect
test
sampl
tabl
figur
present
sensit
specif
method
detect
type
identif
virus
base
molecular
biolog
techniqu
numer
molecular
assay
describ
though
silico
analysi
reveal
major
method
base
sequenc
singl
viral
isol
perform
laboratori
set
limit
data
shown
current
studi
broad
sensit
panel
assay
base
twostep
nest
pcr
develop
detect
major
human
respiratori
virus
select
primer
set
design
base
complet
genbank
inform
complementari
sequenc
archiv
contemporari
viral
strain
approach
limit
influenc
sequenc
variabl
facilit
detect
contemporari
like
newli
emerg
strain
develop
assay
may
thu
consid
detect
techniqu
also
basic
tool
viru
discoveri
main
disadvantag
develop
test
detect
limit
virus
belong
specif
viral
familiessubfamili
use
virus
furthermor
divers
viral
speci
combin
low
load
clinic
sampl
may
result
falseneg
particular
featur
make
assay
inferior
sequenceindepend
method
eg
vidisca
detect
unknown
pathogen
assay
base
degener
primer
offer
far
higher
sensit
base
sequenceindepend
detect
techniqu
detect
unknown
viral
pathogen
respiratori
clinic
materi
difficult
use
sequenceindepend
viru
discoveri
method
low
viral
load
high
background
signal
cellular
nucleic
acid
frequent
hinder
detect
sequenc
independ
viru
discoveri
techniqu
mostli
use
viru
cultur
supernat
contain
highli
concentr
viral
nucleic
acid
discoveri
previous
unknown
dna
virus
thu
far
studi
identifi
novel
human
respiratori
rna
viru
use
sequenc
independ
amplif
techniqu
even
though
sever
improv
propos
sensit
method
inferior
nest
realtim
pcr
current
studi
detect
viral
pathogen
possibl
clinic
sampl
leav
case
undiagnos
detect
rate
consist
previous
publish
report
test
whether
possibl
type
infecti
agent
remain
sampl
molecular
assay
develop
coupl
ex
vivo
cell
cultur
techniqu
base
fulli
differenti
human
airway
epithelium
hae
cultur
constitut
seminatur
environ
replic
viral
pathogen
preamplif
virus
contain
otherwis
neg
clinic
sampl
result
detect
viral
agent
case
observ
compliant
fact
hae
model
superior
cultur
system
term
amplifi
respiratori
virus
hae
cultur
allow
replic
major
respiratori
viral
speci
includ
cultur
cell
line
one
may
question
whether
use
hae
cultur
bia
result
known
human
metapneumoviru
exampl
replic
model
unpublish
observ
assumpt
undoubtedli
correct
although
mention
cultur
model
superior
major
respiratori
virus
unrival
term
viru
discoveri
system
develop
present
studi
detect
respiratori
pathogen
repres
twostag
screen
system
clinic
sampl
test
known
virus
sampl
remain
undiagnos
may
amplifi
ex
vivo
hae
cultur
amplif
may
result
enhanc
detect
virus
clinic
sampl
second
round
test
univers
primer
eventu
identif
obstacl
hinder
detect
pathogen
eg
strain
variabl
presenc
pcr
inhibitor
furthermor
cultur
may
serv
sourc
input
materi
sequenceindepend
amplif
requir
high
viru
yield
good
signalbackground
ratio
conclus
present
studi
describ
set
assay
sensit
low
copi
per
reaction
use
routin
diagnost
laboratori
obtain
result
clearli
show
evalu
test
highli
specif
sensit
thorough
test
show
develop
primer
set
cross
react
respiratori
pathogen
abl
detect
virus
wide
rang
clinic
sampl
hae
cultur
use
preamplif
signal
contain
sampl
facilit
detect
pathogen
standard
pcr
sequenceindepend
method
base
observ
one
may
hypothes
report
lack
etiolog
agent
proport
patient
suffer
respiratori
diseas
may
result
presenc
unknown
viral
speci
also
lack
sensit
avail
assay
studi
includ
vidisca
analysi
provid
greater
insight
epidemiolog
differ
strain
speci
may
possibl
allow
detect
identif
previous
unknown
virus
viru
stock
gener
infect
hela
cell
atcc
adenoviru
rd
cell
atcc
enteroviru
cell
atcc
kind
gift
lia
van
der
hoek
parainfluenza
type
hmpv
hrsv
cell
atcc
influenza
b
case
cell
lyse
appear
cytopath
effect
two
freezethaw
cycl
viruscontain
fluid
aliquot
store
control
cell
lysat
mockinfect
cell
prepar
manner
viru
stock
viru
yield
pathogen
assess
titrat
fulli
confluent
suscept
cell
accord
reed
muench
formula
plate
incub
cytopath
effect
occurr
score
use
invert
microscop
human
coronaviru
parainfluenza
virus
bocaviru
origin
directli
clinic
sampl
process
laboratori
stock
sampl
contain
influenza
viru
human
echoviru
rsv
human
parainfluenza
viru
human
adenoviru
kindli
provid
marcel
muller
human
coronaviru
kind
gift
lia
van
der
hoek
human
metapneumoviru
human
coronaviru
kindli
provid
oliv
schildgen
astrid
vabret
respect
influenza
b
viru
success
isol
laboratori
past
human
tracheobronchi
epitheli
cell
obtain
airway
specimen
resect
patient
undergo
surgeri
silesian
center
heart
diseas
approv
protocol
studi
approv
bioethic
committe
medic
univers
silesia
katowic
poland
approv
date
written
inform
consent
obtain
patient
primari
cell
detach
human
bronchi
trachea
pronas
e
expand
collagenco
collagen
type
iv
sigma
aldrich
plastic
bronchial
epitheli
growth
media
begm
gener
passag
cell
plate
densiti
cell
per
well
permeabl
transwel
insert
corn
transwellclear
support
begm
cell
cultur
presenc
confluenc
human
airway
epithelium
hae
cultur
gener
chang
media
air
liquid
interfac
media
ali
provis
airliquid
interfac
week
form
welldifferenti
polar
cultur
resembl
vivo
pseudostratifi
mucociliari
epithelium
procedur
perform
previous
describ
visual
hae
structur
cultur
transwel
insert
wash
one
time
pb
fix
paraformaldehyd
pb
sampl
incub
min
room
temperatur
membran
detach
plastic
frame
subsequ
membran
wash
pb
dehydr
gradient
ethanol
xylen
paraffin
embed
section
mount
silanis
glass
slide
prior
stain
slide
deparaffin
xylen
rehydr
ethanol
morpholog
hae
cultur
visual
mean
standard
haematoxylin
eosin
method
fluoresc
microscopi
slide
incub
consecut
tween
min
room
temperatur
bovin
serum
albumin
h
room
temperatur
subsequ
immunolocalis
mucin
sampl
incub
mous
monoclon
antirecombin
santa
cruz
dilut
mous
monoclon
antirecombin
mucin
santa
cruz
dilut
respect
goat
antimous
igg
hl
alexa
fluor
invitrogen
dilut
use
secondari
antibodi
nuclear
stain
perform
use
hoechst
sigmaaldrich
section
examin
fluoresc
microscop
nicon
eclips
ti
clinic
sampl
adult
patient
asthma
exacerb
submit
jagiellonian
univers
medic
colleg
krakow
poland
sampl
nasal
wash
obtain
lavag
collect
part
standard
procedur
diagnosi
respiratori
pathogen
studi
approv
bioethic
committe
jagiellonian
univers
krakow
poland
approv
date
extend
written
inform
consent
obtain
patient
follow
collect
sampl
store
order
design
primer
would
recogn
strain
given
viru
irrespect
natur
variabl
genom
sequenc
avail
via
genbank
obtain
sequenc
organ
bioedit
softwar
align
clustalw
script
http
wwwebiacuk
influenza
sequenc
align
set
contain
sequenc
gener
due
limit
align
softwar
conserv
site
sequenc
set
identifi
bioedit
inspect
eye
larger
data
set
visual
basic
script
develop
identifi
presenc
site
conserv
analyz
genom
posit
verifi
term
primer
qualiti
specif
blast
server
http
blastncbinlmnihgovblastcgi
oligoanalyz
http
euidtdnacomanalyzerapplicationsoligoanalyz
order
correct
strain
variabl
part
primer
design
conserv
site
part
degener
requir
rna
clinic
sampl
viral
cultur
supernat
extract
use
rna
mini
kit
biotechnolog
gdynia
poland
accord
manufactur
protocol
dna
isol
use
viral
dnarna
mini
kit
biotechnolog
gdynia
poland
accord
manufactur
instruct
isol
nucleic
acid
store
order
develop
posit
control
easili
quantifi
set
plasmid
contain
dna
fragment
target
dedic
primer
prepar
briefli
isol
rna
revers
transcrib
high
capac
cdna
revers
transcript
appli
biosystem
accord
manufactur
instruct
use
previous
extract
rna
isol
dna
sampl
contain
dna
virus
use
input
pcr
without
process
first
pcr
reaction
conduct
describ
result
mixtur
layer
agaros
gel
follow
gel
separ
dna
fragment
band
correspond
size
expect
product
extract
gel
total
dna
purifi
gelout
kit
biotechnolog
gdynia
poland
dna
concentr
assess
spectrophotometr
clone
instaclon
pcr
clone
kit
fermenta
vector
amplif
e
coli
plasmid
isol
plasmid
mini
kit
biotechnolog
gdynia
poland
ident
clone
cdna
fragment
confirm
dna
sequenc
subsequ
plasmid
dna
linear
ecori
restrict
enzym
fermenta
separ
gel
electrophoresi
purifi
gel
describ
dna
concentr
assess
spectrophotometr
gel
analysi
number
copi
per
ml
calcul
gener
plasmid
use
posit
control
pcr
reaction
isol
nucleic
acid
revers
transcrib
rna
virus
use
input
materi
tworound
pcr
reaction
select
primer
amplif
carri
total
volum
dreamtaq
pcr
master
mix
fermenta
presenc
forward
revers
primer
pcr
nm
pcr
nm
templat
dna
pcr
pcr
first
pcr
touchdown
pcr
protocol
cycl
condit
includ
initi
denatur
minut
follow
cycl
sec
sec
decreas
per
cycl
sec
cycl
sec
sec
sec
follow
min
final
elong
nest
pcr
reaction
prepar
manner
pcr
mixtur
templat
cycl
condit
nest
pcr
consist
initi
denatur
min
follow
cycl
sec
sec
sec
addit
min
final
elong
follow
nest
pcr
whole
sampl
analyz
influenza
assay
assay
agaros
gel
visual
ethidium
bromid
order
determin
sensit
assay
serial
dilut
linear
posit
control
plasmid
use
concentr
rang
copi
per
reaction
pcr
nest
pcr
conduct
describ
analysi
perform
standard
gel
electrophoresi
assay
evalu
cell
cultur
materi
clinic
sampl
posit
rsv
influenza
b
virus
parainfluenza
virus
human
bocaviru
adenoviru
type
human
metapneumoviru
human
echoviru
viru
stock
dilut
cultur
media
clinic
sampl
test
neg
known
pathogen
includ
sputum
bronchioalveolar
lavag
nasal
lavag
viral
nucleic
acid
isol
describ
revers
transcrib
appropri
concentr
viral
sampl
test
primer
set
tworound
pcr
valid
assay
evalu
virus
use
studi
includ
influenza
b
virus
parainfluenza
virus
bocaviru
rsv
human
adenoviru
human
metapneumoviru
human
echoviru
